Study of a Smart Sharps Disposal Device in Patients With Hemophilia
NCT07421154 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2026-04-23
Summary
This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.
Conditions
- Hemophilia A and B
Interventions
- OTHER
-
The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
Sponsors & Collaborators
-
Sharpscue
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Allyson Pishko, MD · University of Pennsylvania
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2027-01-30
- Completion
- 2027-01-30
Countries
- United States
Study Locations
More Related Trials
-
PF-06741086 Multiple Dose Study in Severe Hemophilia
NCT02974855 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
NCT07220564 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
NCT03587116 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
NCT05135559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B
NCT01228669 ·Status: COMPLETED ·Phase: PHASE1
-
PK Driven Prophylaxis for Hemophilia A
NCT02634424 ·Status: TERMINATED ·Phase: NA
-
KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors
NCT06747416 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
NCT03432520 ·Status: ACTIVE_NOT_RECRUITING
-
Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A
NCT02256917 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A
NCT01205724 ·Status: COMPLETED ·Phase: PHASE1
-
Emicizumab in Patients With Acquired Hemophilia A
NCT05345197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
NCT03407651 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
NCT01392547 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
NCT02476942 ·Status: COMPLETED
-
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
NCT03938792 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
NCT05911763 ·Status: ACTIVE_NOT_RECRUITING
-
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
NCT04805021 ·Status: RECRUITING
-
rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors
NCT01105546 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors
NCT06312475 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
NCT00995046 ·Status: TERMINATED ·Phase: NA
-
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
NCT05568719 ·Status: RECRUITING ·Phase: PHASE3
-
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
NCT03528551 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating ReFacto AF in Severe Hemophilia A
NCT00037544 ·Status: COMPLETED ·Phase: PHASE3
-
Emicizumab in Acquired Hemophilia A
NCT04188639 ·Status: COMPLETED ·Phase: PHASE2